Showing results (51-60 of 71) with videos related to
Sort By:
Pageof 8
Neuro-Oncology Advances|September 29, 2023
Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastomaMame Daro Faye, Jacob Easaw, Paula De Robles, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014
p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinomaChristine H Chung, Qiang Zhang, Christina S Kong, et al.Oral Oncology|March 29, 2026
Predicting treatment intolerance in operable head and neck cancer using the modified head and neck surgery risk indexMarco A Mascarella, Alex Mlynarek, Keith Richardson, et al.International Journal of Radiation Oncology, Biology, Physics|May 24, 2016
Correlation Between the Severity of Cetuximab-Induced Skin Rash and Clinical Outcome for Head and Neck Cancer Patients: The RTOG ExperienceVoichita Bar-Ad, Qiang Ed Zhang, Paul M Harari, et al.JAMA Otolaryngology-- Head & Neck Surgery|December 5, 2024
Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Human Papillomavirus-Related Oropharyngeal CancerNader Sadeghi, Thavakumar Subramaniam, Keith Richardson, et al.Pilot and Feasibility Studies|December 21, 2024
PTSD Coach as an early mobile intervention to improve cancer-related anxiety and psychosocial oncology uptake in patients newly diagnosed with head and neck cancer: pilot randomized controlled trialLaurence Ducharme, Chris Lo, Michael Hier, et al.Current Oncology (Toronto, Ont.)|July 25, 2022
Biopsychosocial Markers of Body Image Concerns in Patients with Head and Neck Cancer: A Prospective Longitudinal StudyJustine G Albert, Christopher Lo, Zeev Rosberger, et al.The Lancet. Oncology|June 27, 2024
Assessment of endpoint definitions in curative-intent trials for mucosal head and neck squamous cell carcinomas: Head and Neck Cancer International Group consensus recommendationsAnnette M Lim, Lachlan McDowell, Chris Hurt, et al.Head & Neck|November 3, 2021
Risk stratification after recurrence of human papillomavirus (HPV)-related and non-HPV-related oropharyngeal cancer: Secondary analysis of NRG Oncology RTOG 0129 and 0522Elaine O Bigelow, Jonathan Harris, Carole Fakhry, et al.Journal of the National Cancer Institute|April 6, 2006
Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patientsFadlo R Khuri, J Jack Lee, Scott M Lippman, et al.Pageof 8